The Royal Brisbane and Women’s Hospital (RBWH) Swallowing and Nutrition Management Guidelines for Patients with Head and Neck Cancer were developed to enable evidence-based decision-making by the Head and Neck Multidisciplinary Team (H&N MDT) regarding enteral nutrition support options. The purpose of this study was to revalidate these guidelines in a cohort of patients receiving helical intensity-modulated radiotherapy (H-IMRT) compared to a historical cohort who received primarily 3D-conformal radiotherapy. Eligible patients attending the RBWH H&N MDT between 2013 and 2014 (n = 315) were assessed by the guidelines, with high-risk patients being recommended proactive gastrostomy tube placement. Data were collected on guideline adherence, gastrostomy tube insertions, the duration of enteral tube use and weight change. Sensitivity, specificity and positive predictive and negative predictive values were calculated and compared with the historical cohort. Overall guideline adherence was 84%, with 60% and 96% adherence to the high-risk and low-risk pathways, respectively. Seventy patients underwent proactive gastrostomy tube placement (n = 62 high-risk; n = 8 low-risk). Validation outcomes were sensitivity 73% (compared to 72%) and specificity 86% (compared to 96%). The guidelines yielded a high sensitivity and specificity, remaining valid in a cohort of patients treated with H-IMRT. Further studies are recommended to improve the sensitivity and understand the decrease in specificity in order to make ongoing guideline improvements.
Purpose: There are no clinical guidelines for micronutrient supplementation and monitoring during the post-acute phase of Stem cell transplantation (SCT) and during graft versus host disease (GVHD). Hence this comprehensive systematic review aimed to evaluate the evidence for vitamin and mineral supplementation and monitoring to inform clinical practice. Methods: Eligible studies included adults who had undergone SCT more than 100 days ago or were experiencing GVHD and were prescribed a micronutrient supplement and/or had micronutrient levels monitored. Human studies published in English were retrieved from five databases (Embase, Medline, Scopus, Web of Science, and CINAHL) on the 24th of May 2024. The risk of bias and certainty of evidence were assessed through the Academy of Nutrition and Dietetics Quality Criteria Checklist and The Grading of Recommendations, Assessment, Development and Evaluation (GRADE) system. No meta-analysis was completed as part of this systematic review. Results: Sixteen studies (n = 1573) met eligibility criteria for inclusion. Micronutrients examined by these studies were vitamin D, calcium, and vitamin A. All studies had a neutral risk of bias. Studies reported variable prevalence of vitamin D deficiency, with mixed results regarding the association between vitamin D or calcium and the outcomes of reduced bone mineral density (BMD), chronic GVHD, mortality, sarcopenia, or fractures. The GRADE certainty of evidence for vitamin D or calcium and BMD was very low. Conclusion: The impact of micronutrient supplementation on clinical outcomes is unclear, however, monitoring vitamin D levels and calcium intake after SCT should be considered to detect deficiency or inadequate intake.